BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6800026)

  • 21. Summary--bone metastasis.
    Donahue HJ
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):381-2. PubMed ID: 15758270
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone remodeling.
    Parfitt AM
    Henry Ford Hosp Med J; 1988; 36(3):143-4. PubMed ID: 3250946
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypercalcemia of malignancy. Animal model: VX-2 carcinoma of rabbits.
    Young DM; Ward JM; Prieur DJ
    Am J Pathol; 1978 Nov; 93(2):619-22. PubMed ID: 717539
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment.
    Parfitt AM
    Can J Oncol; 1995 Dec; 5 Suppl 1():1-10. PubMed ID: 8853518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenesis of bone metastasis and tumor osteopathies].
    Krempien B
    Radiologe; 1995 Jan; 35(1):1-7. PubMed ID: 7892437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mechanisms of bone resorption].
    Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1860-1. PubMed ID: 7330639
    [No Abstract]   [Full Text] [Related]  

  • 27. The dual role of IL-6-type cytokines on bone remodeling and bone tumors.
    Blanchard F; Duplomb L; Baud'huin M; Brounais B
    Cytokine Growth Factor Rev; 2009 Feb; 20(1):19-28. PubMed ID: 19038573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteotropic cancers: from primary tumor to bone.
    Buijs JT; van der Pluijm G
    Cancer Lett; 2009 Jan; 273(2):177-93. PubMed ID: 18632203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular targets for the treatment of bone metastases].
    Hiraga T
    Clin Calcium; 2006 Jan; 16(1):159-65. PubMed ID: 16397367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercalcemic VX-2 carcinoma in rabbits: a clinicopathologic study.
    Young DM; Fioravanti JL; Prieur DJ; Ward JM
    Lab Invest; 1976 Jul; 35(1):30-46. PubMed ID: 940320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of tumor promoters on arachidonic acid metabolism by cells in culture.
    Levine L
    Carcinog Compr Surv; 1982; 7():477-94. PubMed ID: 6802494
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of PGE2 in bone metastatic cancer].
    Inada M; Miyaura C
    Clin Calcium; 2008 Apr; 18(4):466-72. PubMed ID: 18379028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of lytic and blastic metastatic disease of bone.
    Galasko CS
    Clin Orthop Relat Res; 1982 Sep; (169):20-7. PubMed ID: 7105580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The VX-2 carcinoma: humoral effects and arachidonic acid metabolism.
    Hubbard WC; Hough A; Brash AR; Johnson RM; Oates JA
    Adv Prostaglandin Thromboxane Res; 1980; 6():525-7. PubMed ID: 7386286
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RANKL signaling in bone physiology and cancer.
    Dougall WC
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):317-22. PubMed ID: 18685382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin synthesis by isolated cells from the outer medulla and from the thick ascending loop of Henle of rabbit kidney.
    Schlondorff D; Zanger R; Satriano JA; Folkert VW; Eveloff J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):120-4. PubMed ID: 6811729
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
    Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
    Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.